Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,787,366
  • Shares Outstanding, K 124,339
  • Annual Sales, $ 55,660 K
  • Annual Income, $ -46,450 K
  • 60-Month Beta N/A
  • Price/Sales 49.52
  • Price/Cash Flow N/A
  • Price/Book 6.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.25 +18.46%
on 01/23/20
32.17 -3.36%
on 01/28/20
+1.82 (+6.22%)
since 12/27/19
3-Month
25.07 +24.01%
on 10/31/19
33.40 -6.92%
on 12/23/19
+5.00 (+19.16%)
since 10/28/19

Most Recent Stories

More News
Adaptive Announces Pricing of Public Offering of Common Stock

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

JPM : 134.43 (+1.82%)
ADPT : 31.09 (+2.07%)
Adaptive Announces Proposed Public Offering of Common Stock

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

JPM : 134.43 (+1.82%)
ADPT : 31.09 (+2.07%)
Adaptive Announces Preliminary Unaudited Revenue for Full Year 2019

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 31.09 (+2.07%)
Adaptive and Genentech Partner to Use clonoSEQ(R) Assay to Measure Minimal Residual Disease as a Primary Endpoint in Phase III Study of Chronic Lymphocytic Leukemia Patients

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 31.09 (+2.07%)
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ(R) for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 31.09 (+2.07%)
Adaptive Biotechnologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San...

JPM : 134.43 (+1.82%)
ADPT : 31.09 (+2.07%)
Top Ranked Momentum Stocks to Buy for December 30th

Top Ranked Momentum Stocks to Buy for December 30th

SNE : 72.02 (+1.00%)
HQY : 71.99 (+2.54%)
BMY : 64.81 (+1.74%)
ADPT : 31.09 (+2.07%)
Adaptive Biotechnologies Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Adaptive Biotechnologies.

ADPT : 31.09 (+2.07%)
Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ(R) Assay

Adaptive Biotechnologies Corporation (Nasdaq:ADPT) today announced a multi-year, global collaboration agreement with AbbVie (NYSE: ABBV) to utilize Adaptive's next-generation sequencing (NGS)-based clonoSEQ...

ADPT : 31.09 (+2.07%)
ABBV : 83.77 (-0.30%)
Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ(R) Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients

Research and real-world evidence support the use across a range of leukemias and lymphomas and demonstrate utility in multiple tissue types, including blood and bone marrow

ADPT : 31.09 (+2.07%)
Trade ADPT with:

Business Summary

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage....

See More

Key Turning Points

2nd Resistance Point 33.15
1st Resistance Point 32.12
Last Price 31.09
1st Support Level 30.11
2nd Support Level 29.13

See More

52-Week High 55.12
Fibonacci 61.8% 43.25
Fibonacci 50% 39.59
Fibonacci 38.2% 35.92
Last Price 31.09
52-Week Low 24.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar